Fatal Familial Infantile Myelofibrosis

Journal of Pediatric Hematology/Oncology

Volumn 26, Issue 3, 2004, Pages 164-168

  Sheikha, Anwar ^a,b  

^a KING KHALID UNIVERSITY   (Saudi Arabia)

^b KING KHALID UNIVERSITY   (Saudi Arabia)

Author keywords

Acute megakaryoblastic leukemia; Acute panmyelosis with myelofibrosis; Familial infantile myelofibrosis; Familial myelofibrosis; Infantile myelofibrosis

Indexed keywords

ACUTE MEGAKARYOCYTIC LEUKEMIA; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CASE REPORT; CELL PROLIFERATION; CONSANGUINEOUS MARRIAGE; CYTOKINE RELEASE; DOWN SYNDROME; FAMILIAL DISEASE; FATAL FAMILIAL INFANTILE MYELOFIBROSIS; FEMALE; GENE MUTATION; HUMAN; INFANT; INFANT DISEASE; MALE; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL;

ADULT; FATAL OUTCOME; FEMALE; HUMANS; INFANT; LEUKEMIA, MEGAKARYOCYTIC, ACUTE; MALE; MYELOFIBROSIS; PLATELET COUNT;

EID: 1542316951     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200403000-00005     Document Type: Article

References (45)

1. Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med. 2000;342:1255-1265.
2. Ward HP, Black MH. The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine (Baltimore). 1971;50:357-420.
3. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;100:2292-2302.
4. Harris NL, Jaffe ES, Diebold J, et al. World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting - Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835-3849.
5. Bennett JM, Catovsky D, Daniel MT, et al. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7): a report of the French-American-British Cooperative Group. Ann Intern Med. 1985;103:460-462.
6. Sultan C, Sigaux F, Imber TM, et al. Acute myelodysplasia with myelofibrosis: a report of eight cases. Br J Haematol. 1981;49:11-16.
7. Fabich DR, Raich PC. Acute myelofibrosis: a report of three cases. Am J Clin Pathol. 1977;67:334-336.
8. Bearman RM, Pangalis GA, Rappaport H. Acute ("malignant") myelosclerosis. Cancer. 1979;43:279-293.
9. Lewis SM, Szur MB. Malignant myelosclerosis. Br Med J. 1963;ii:472-473.
10. Bird T, Proctor S. Malignant myelosclerosis: Myeloproliferative disorder or leukemia. Am J Clin Pathol. 1977;67:512-520.
11. Tallman MS, Neuberg D, Bennett JM, et al. Acute megakaryoblastic leukemia: the Eastern Cooperative Oncology Group experience. Blood. 2000;96:2405-2411.
12. Pagano L, Pulsoni A, Vignetti M, et al. Acute megakaryoblastic leukemia: experience of GIMEMA trials. Leukemia. 2002;16:162-206.
13. Das S, Prabhakar BR. Acute myelofibrosis. Indian J Pathol Microbiol. 1997;40:527-530.
14. Pui CH. Childhood leukemias. N Engl J Med. 1995;332:1618-1630.
15. Athale UH, Razzouk BI, Riamondi SC, et al. Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution's experience. Blood. 2001;97:3727-3732.
16. Zipursky A, Peeters M, Poon A. Megakaryoblastic leukemia and Down's syndrome - a review. Prog Clin Biol Res. 1987;246:33-56.
17. Zipursky A, Brown E, Christensen H, et al. Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome. Semin Perinatol. 1997;21:97-101.
18. Zubizarreta P, Felice MS, Alfaro E, et al. Acute myelogenous leukemia in Down's syndrome: report of a single pediatric institution using a BFM treatment strategy. Leuk Res. 1998;22:465-472.
19. Lange BJ, Kobrinsky N, Barnard DR, et al. Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down Syndrome: Children's Cancer Group studies 2861 and 2891. Blood. 1998;91:608-615.
20. Ravindranath Y, Abella E, Krischer JP, et al. Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience of Pediatric Oncology Group AML study 8498. Blood. 1992;80:2210-2214.
21. Chan WC, Carroll A, Alvarado CS, et al. Acute megakaryoblastic leukemia in infants with t(1;22)(p13;q13) abnormality. Am J Clin Pathol. 1992;98:214-221.
22. Oshima M, Fukushima T, Koike K, et al. Infant leukemia with t(1;22) presenting proliferation of erythroid and megakaryocytic cell lineages. Rinsho Ketsueki. 1999;40:230-235.
23. Suttorp M, Polchau H, Kuhn B, et al. Acute megakaryoblastic leukemia (FAB-M7) in an infant presenting with orbital chloroma and meningeal involvement. Haematol Blood Transfus. 1990;31:368-373.
24. Penchansky L, Taylor SR, Krause JR. Three infants with acute megakaryoblastic leukemia simulating metastatic tumor. Cancer. 1989;64:1366-1371.
25. Gilbert HS. Familial myeloproliferative diseases. In: Wasserman LR, Berk PD, Berlin NI, eds. Polycythemia vera and myeloproliferative disorders, 1st ed. Philadelphia: WB Saunders, 1995:222-225.
26. Kaufman S, Briere J, Bernard J. Familial myeloproliferative syndromes. Study of 6 families and review of literature. Nouv Rev Fr Hematol. 1978;14:1-15.
27. Sieff CA, Malleson P. Familial myelofibrosis. Arch Dis Child. 1980;55:888-893.
28. Mallouh AA. Sa'di AR. Agnogenic myeloid metaplasia in children. Am J Dis Child. 1992;146:965-967.
29. Sheikha A. Familial infantile myelofibrosis [abstract 4105]. Blood. 1998;92:256b (Supplement 1).
30. Nix WL, Fernbach DJ. Myeloproliferative diseases in childhood. Am J Pediatr Hematol Oncol. 1981;3:397-407.
31. Ng KC, Tan AM, Chong YY, et al. Congenital acute megakaryoblastic leukemia (M7) with chromosomal t(1;22)(p13;q13) translocation in a set of identical twins. J Pediatr Hematol Oncol. 1999;21:428-430.
32. Anwar Sheikha M. Al-Janadi, J. Malik, et al. Visceral leishmaniasis with a very low degree of bone marrow parasitemia, mimicking malignant histiocytosis. Intern J Oncol. 1993;3:477-480.
33. San Miguel JF, Gonzales M, Canizo MC, et al. Leukemia with megakaryoblastic involvement: clinical, hematological and immunological characteristics. Blood. 1988;72:402-407.
34. Bhatia S, Neglia JP. Epidemiology of childhood acute myelogenous leukemia. J Pediatr Hematol Oncol. 1995;17:94-100.
35. Zipursky A, Poon A, Doyle J. Leukemia in Down syndrome: a review. Pediatr Hematol Oncol. 1992;9:139-149.
36. Ruiz-Arguelles GJ, Lobato-Mendizabal E, San-Miguel JF, et al. Longterm treatment results for acute megakaryoblastic leukemia patients: a multicentre study. Br J Haematol. 1992;82:671-675.
37. Truong LD, Saleem A, Schwartz MR. Acute myelofibrosis. A report of four cases and review of literature. Medicine (Baltimore). 1984;63:182-187.
38. Dastugue N, Lafage-Pochitaloff M, Pages MP, et al. Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): a study of the Groupe Francais de Cytogenetique Hematologique (GFCH). Blood. 2002;100:618-626.
39. Zipursky A, Rivard G, Freedman MH. Differentiation of leukemic megakaryoblasts in Down syndrome. Leuk Res. 1994;18:163-171.
40. Carroll A, Civin C, Schneider N, et al. The t(1;22)(p13;q13) is nonrandom and restricted to infants with acute megakaryoblastic leukemia: a Pediatric Oncology Group study. Blood. 1991;78:748-752.
41. Lion T, Haas O-A. Harbott, et al. The translocation t(1;22)(p13;q13) is a nonrandom marker specifically associated with acute megakaryoblastic leukemia in young children. Blood. 1992;79:3325-3330.
42. Carroll WL, Morgan R, Glader BE. Childhood bone marrow monosomy 7 syndrome: A familial disorder. J Pediatr. 1985;107:578.
43. Shannon KM, Turhan AG, Roger PC, et al. Evidence implicating heterozygous deletion of chromosome 7 in the pathogenesis of familial leukemia associated with monosomy 7. Genomics. 1992;14:121.
44. Luna-Fineman S, Shannon K, Lange B. Childhood monosomy 7: Epidemiology, biology and mechanistic implications. Blood. 1995;85:1985.
45. Luna-Fineman S, Shannon K, Atwater SK, et al. Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients. Blood. 1999;93:459-466.